Million Bladder

Zydus Life Settles Patent Dispute with Astellas for $120 Million Over Bladder Medication

Zydus Life Sciences, an Indian pharmaceutical company, has reached a $120 million settlement agreement with Astellas Pharma Inc. to resolve ongoing patent litigation related to the bladder drug mirabegron. The settlement ends the dispute over patent rights in the United States, allowing both parties to avoid protracte…